Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss.
Dahari
Harel
H
Perelson
Alan S
AS
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics* / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D022781:Hepatocytes / Q000473:pathology / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D012367:RNA, Viral / Q000187:drug effects / Q000378:metabolism*; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects* / Q000502:physiology
D000998:Antiviral Agents; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin